Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A new generation of cancer diagnostic devices has been unveiled by Singapore-based Clearbridge BioMedics, following its work with product development firm Cambridge Consultants. The new ClearCell FX System is designed to improve cancer diagnosis and treatment monitoring by allowing doctors to rapidly isolate circulating tumour cells (CTCs) in a patient’s bloodstream – paving the way for more personalised medicine.
Hey, check out all the engineering jobs. Post your resume today!
